You are here

  • Home
  • Archive
  • Volume 9, Issue 12
  • Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases

Article metrics

Article menu

Download PDFPDF

Clinical/translational cancer immunotherapy
Original research
Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases

 

Online download statistics by month:

Online download statistics by month: December 2021 to July 2025

AbstractFullPdf
Dec 2021560565146
Jan 2022512529111
Feb 202225926582
Mar 202211812247
Apr 202212413149
May 20229610041
Jun 202215515940
Jul 202212512526
Aug 202212913228
Sep 202215716051
Oct 202211911923
Nov 2022636524
Dec 2022474713
Jan 2023545428
Feb 2023555518
Mar 2023535429
Apr 2023313110
May 2023464615
Jun 2023717120
Jul 2023474721
Aug 2023666915
Sep 2023494915
Oct 2023353512
Nov 2023595918
Dec 202310810818
Jan 2024353620
Feb 2024363620
Mar 2024404048
Apr 2024495231
May 2024222314
Jun 2024424117
Jul 2024525326
Aug 2024232315
Sep 2024394119
Oct 2024414124
Nov 2024373815
Dec 2024757724
Jan 2025979734
Feb 202513513525
Mar 2025686837
Apr 2025646433
May 2025525325
Jun 2025292913
Jul 2025110
Total407541451340